+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioinformatics Market by Technology and Services, Application, and Sector: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828944
  • Report
  • March 2019
  • Region: Global
  • 284 pages
  • Allied Analytics LLP
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
The global bioinformatics market generated $6,389.00 million in 2017, and is projected to reach $18,233.00 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025

Bioinformatics is the combination of information technology, statistics, molecular biology, and algorithms to analyze the data obtained from various experiments. It includes collecting biological data, preparation of a computational model, solving computational modeling problems, and evaluation of computational algorithm. Bioinformatics uses computation to extract knowledge from biological data, which can be used in drug discovery and developments.

The global bioinformatics market is expected to register substantial growth in the near future, owing to rise in need for integrated data and increase in applications of proteomics & genomics. In addition, drug discovery & development is expected to boost the market growth during the forecast period. However, lack of skilled personnel and common data formats is projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems is expected to offer lucrative opportunities for market players.

The global bioinformatics market is segmented based on technology & services, application, sector, and region. By technology, the market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. Based on application, it is classified into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, and others. Depending on sector, it is segregated into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global bioinformatics market is provided.
KEY MARKET SEGMENTS
  • By Technology & Services
o Knowledge Management Tools
  • Generalized Knowledge Management Tools
  • Specialized Knowledge Management Tools
o Bioinformatics Platforms
  • Sequence Analysis Platforms
  • Sequence Alignment Platforms
  • Sequence Manipulation Platforms
  • Structural Analysis Platforms
  • Others
o Bioinformatics Services
  • Sequencing Services
  • Database & Management
  • Data Analysis
  • Others
  • By Application
o Metabolomics
o Molecular Phylogenetics
o Transcriptomics
o Proteomics
o Chemoinformatics
o Genomics
o Others
  • By Sector
o Medical Bioinformatics
o Animal Bioinformatics
o Agriculture Bioinformatics
o Academics
o Others
  • By Region
o North America
  • U.S.
  • Canada
  • Mexico
o Europe
  • Germany
  • France
  • UK
  • Italy
  • Sweden
  • Rest of Europe
o Asia-Pacific
  • Australia
  • Japan
  • India
  • Vietnam
  • Rest of Asia-Pacific
o LAMEA
  • Nigeria
  • Malawi
  • Zambia
  • Rest of LAMEA
KEY MARKET PLAYERS
  • Agilent Technologies, Inc.
  • Geneva Bioinformatics (Genebio)
  • Dassault Systems
  • Eurofins Scientific
  • Illumina Inc.
  • Bruker Daltonics Inc.
  • Biomax Informatics AG
  • Perkinelmer Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
The other players in the value chain include (profiles not included in the report):
  • Accelrys, Inc.
  • Affymetrix, Inc.
  • SA Nonlinear Dynamics
  • Quest Diagnostics, Inc.
Note: Product cover images may vary from those shown
2 of 4
Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2: EXECUTIVE SUMMARY
2.1. CXO perspective

Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning/ market share analysis 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in need for integrated data
3.4.1.2. Increase in growth in proteomics & genomics
3.4.1.3. Drug discovery and development
3.4.2. Restraints
3.4.2.1. Lack of skilled personnel
3.4.2.2. Common data formats
3.4.3. Opportunity
3.4.3.1. Increase in need for integrated solutions & systems
3.5. Porter’s five forces analysis
3.6. Key Regulations
3.7. Value chain analysis
3.8. Bioinformatics in the drug development process
3.9. Patent analysis
3.10. Case studies

Chapter 4: BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Knowledge Management Tools
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Generalized knowledge management tools
4.2.2.1.1. Market size and forecast
4.2.2.2. Specialized knowledge management tools
4.2.2.2.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Bioinformatics Platforms
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Sequence analysis platforms
4.3.2.1.1. Market size and forecast
4.3.2.2. Sequence alignment platforms
4.3.2.2.1. Market size and forecast
4.3.2.3. Sequence manipulation platforms
4.3.2.3.1. Market size and forecast
4.3.2.4. Structural analysis platforms
4.3.2.4.1. Market size and forecast
4.3.2.5. Others
4.3.2.5.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
4.4. Bioinformatics Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Sequencing services
4.4.2.1.1. Market size and forecast
4.4.2.2. Database and management
4.4.2.2.1. Market size and forecast
4.4.2.3. Data Analysis
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country

Chapter 5: BIOINFORMATICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Genomics
5.2.1. Metagenomics
5.2.2. Population genomics
5.2.3. Market size and forecast, by region
5.2.4. Market analysis, by country
5.3. Chemoinformatics and Drug Design
5.3.1. Market Size and Forecast, By Region
5.3.2. Market analysis, by country
5.4. Proteomics
5.4.1. Market Size and Forecast, by region
5.4.2. Market analysis, by country
5.5. Transcriptomics
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Metabolomics
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Molecular Phylogenetics
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Other application market
5.8.1. Pharmacogenomics
5.8.2. Pharmacoproteomics
5.8.2.1. Market size and forecast
5.8.3. Market analysis, by country

Chapter 6: GLOBAL BIOINFORMATICS MARKET BY SECTOR
6.1. Overview
6.1.1. Market size and forecast, by region
6.2. Medical bioinformatics
6.2.1. Drug development
6.2.2. Molecular medicine
6.2.3. Preventive medicine
6.2.4. Gene therapy
6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country
6.3. Animal Bioinformatics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Agricultural bioinformatics
6.4.1. Crop yield improvement
6.4.2. Pest resistance
6.4.3. Plant resistance against abiotic stresses
6.4.4. Improve nutritional quality
6.4.5. Market size and forecast by region
6.4.6. Market analysis, by country
6.5. Academics
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
6.6. Others (Microbial genome)
6.6.1. Market size and forecast, by region
6.6.2. Market analysis, by country

Chapter 7: BIOINFORMATICS MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America bioinformatics market, by country
7.2.2.1. U.S. bioinformatics market, by technology and services
7.2.2.2. U.S. bioinformatics market, by application
7.2.2.3. U.S. bioinformatics market, by sector
7.2.2.4. Canada bioinformatics market, by technology and services
7.2.2.5. Canada bioinformatics market, by Application
7.2.2.6. Canada bioinformatics market, by sector
7.2.2.7. Mexico bioinformatics market, by technology and services
7.2.2.8. Mexico bioinformatics market, by application
7.2.2.9. Mexico bioinformatics market, by sector
7.2.3. North America bioinformatics market, by technology and services
7.2.4. North America bioinformatics market, by Application
7.2.5. North America bioinformatics market, by Sector
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe bioinformatics market, by country
7.3.2.1. Germany bioinformatics market, by technology and services
7.3.2.2. Germany bioinformatics market, by application
7.3.2.3. Germany bioinformatics market, by sector
7.3.2.4. France bioinformatics market, by technology and services
7.3.2.5. France bioinformatics market, by application
7.3.2.6. France bioinformatics market, by sector
7.3.2.7. UK bioinformatics market, by technology and services
7.3.2.8. UK bioinformatics market, by application
7.3.2.9. UK bioinformatics market, by sector
7.3.2.10. Italy bioinformatics market, by technology and services
7.3.2.11. Italy bioinformatics market, by application
7.3.2.12. Italy bioinformatics market, by sector
7.3.2.13. Spain bioinformatics market, by technology and services
7.3.2.14. Spain bioinformatics market, by application
7.3.2.15. Spain bioinformatics market, by sector
7.3.2.16. Rest of Europe bioinformatics market, by technology and services
7.3.2.17. Rest of Europe bioinformatics market, by application
7.3.2.18. Rest of Europe bioinformatics market, by sector
7.3.3. Europe bioinformatics market, by technology and services
7.3.4. Europe bioinformatics market, by application
7.3.5. Europe bioinformatics market, by sector
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific bioinformatics market, by country
7.4.2.1. Japan bioinformatics market, by technology and services
7.4.2.2. Japan bioinformatics market, by Application
7.4.2.3. Japan bioinformatics market, by sector
7.4.2.4. China bioinformatics market, by technology and services
7.4.2.5. China bioinformatics market, by application
7.4.2.6. China bioinformatics market, by sector
7.4.2.7. India bioinformatics market, by technology and services
7.4.2.8. India bioinformatics market, by application
7.4.2.9. India bioinformatics market, by sector
7.4.2.10. Australia bioinformatics market, by technology and services
7.4.2.11. Australia bioinformatics market, by application
7.4.2.12. Australia bioinformatics market, by sector
7.4.2.13. South Korea bioinformatics market, by technology and services
7.4.2.14. South Korea bioinformatics market, by application
7.4.2.15. South Korea bioinformatics market, by sector
7.4.2.16. Taiwan bioinformatics market, by technology and services
7.4.2.17. Taiwan bioinformatics market, by Application
7.4.2.18. Taiwan bioinformatics market, by sector
7.4.2.19. Rest of Asia-Pacific bioinformatics market, by technology and services
7.4.2.20. Rest of Asia-Pacific bioinformatics market, by application
7.4.2.21. Rest of Asia-Pacific bioinformatics market, by sector
7.4.3. Asia-Pacific bioinformatics market, by technology and services
7.4.4. Asia-Pacific bioinformatics market, by application
7.4.5. Asia-Pacific bioinformatics market, by sector
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA bioinformatics market, by country
7.5.2.1. Brazil bioinformatics market, by technology and services
7.5.2.2. Brazil bioinformatics market, by application
7.5.2.3. Brazil bioinformatics market, by sector
7.5.2.4. Saudi Arabia bioinformatics market, by technology and services
7.5.2.5. Saudi Arabia bioinformatics market, by application
7.5.2.6. Saudi Arabia bioinformatics market, by sector
7.5.2.7. South Africa bioinformatics market, by technology and services
7.5.2.8. South Africa bioinformatics market, by application
7.5.2.9. South Africa bioinformatics market, by sector
7.5.2.10. Rest of LAMEA bioinformatics market, by technology and services
7.5.2.11. Rest of LAMEA bioinformatics market, by application
7.5.2.12. Rest of LAMEA bioinformatics market, by sector
7.5.3. LAMEA bioinformatics market, by technology and services
7.5.4. LAMEA bioinformatics market, by application
7.5.5. LAMEA bioinformatics market, by sector

Chapter 8: COMPANY PROFILES
8.1. AGILENT TECHNOLOGIES, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIOMAX INFORMATICS AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Key strategic moves and developments
8.3. BRUKER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. DASSAULT SYSTEMES
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.5. EUROFINS SCIENTIFIC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Business performance
8.6. GENEVA BIOINFORMATICS (GENEBIO) S.A.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. ILLUMINA, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. PERKINELMER INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. QIAGEN N.V.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. THERMO FISHER SCIENTIFIC, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4
According to this report titled, 'Bioinformatics Market by Technology & Services, Application, and Sector: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global bioinformatics market size is $6,389 million in 2017, and is projected to reach $18,233 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The bioinformatics platforms segment accounted for nearly half of the total bioinformatics market share in 2017.

Bioinformatics is the conceptualization of biology, in terms of molecules, along with application of information technology to organize and understand the data associated with these molecules on a large scale. Bioinformatics utilizes computer to collect, analyze, integrate, and store the molecular and biological data, which is subsequently utilized in applications, such as drug development and discovery. Technology and services are the two important segments of this market.

The bioinformatics market is expected to exhibit significant growth during the forecast period, due to rise in need for integrated data and increase in applications of proteomics & genomics. In addition, drug discovery & development is expected to boost the market growth during the forecast period. However, lack of skilled personnel and common data formats are projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems is expected to offer remunerative opportunities for market players.

Based on application, the market is classified into matabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, and others. In 2017, the genomics segment garnered the leading position, in terms of revenue, owing to wide applications and usage of genomics in sequencing of biomolecules.

Region wise, the bioinformatics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2017, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to upsurge in adoption of advanced technology and increase in demand for advanced bioinformatics tools, which are required in the drug discovery and development process.

The report provides a comprehensive analysis of the key players operating in the global bioinformatics industry, namely, Agilent Technologies, Inc., Geneva Bioinformatics (Genebio), Dassault Systems, Eurofins Scientific, Illumina Inc., Bruker Daltonics Inc., Biomax Informatics AG, Perkinelmer Inc., Qiagen N.V, and Thermo Fisher Scientific, Inc. The other players in the value chain include Accelrys, Inc., Affymetrix, Inc., SA Nonlinear Dynamics, Quest Diagnostics, Inc., and others.

Key Findings of the Bioinformatics Market:

Based on technology & services, the bioinformatics services segment is expected to experience rapid growth in the market, registering a CAGR of 25.1% from 2018 to 2025.
By sector, the medical bioinformatics segment was the major revenue contributor in 2017, and is anticipated to continue bioinformatics market trends during the forecast period.
Depending on application, the transcriptomics segment is expected to exhibit the highest CAGR during the forecast period.
U.S. generated the highest revenue in the global bioinformatics industry in 2017, accounting nearly two-fifths of the global market in 2017.
LAMEA is estimated to grow at a CAGR of 15.7% during the forecast period.
Note: Product cover images may vary from those shown
4 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll